Sanofi SNY and partner Regeneron REGN announced that the FDA has accepted their resubmitted supplemental biologics license application (sBLA) seeking approval of Dupixent for the treatment of chronic spontaneous...
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -1.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.40%. Stocks retreated...
Dupixent's resubmission for FDA review includes pivotal data showing significant reduction in itch and hive activity for CSU patients.Quiver AI SummaryRegeneron Pharmaceuticals and Sanofi have announced...
Their recent issues are nothing to fret over for investors focused on the long game.
Bayer AG BAYRY reported third-quarter 2024 core earnings of 7 cents per American Depositary Receipt (ADR), which missed the Zacks Consensus Estimate of 17 cents. The company reported earnings of 10 cents...
Check out these three stocks with financial metrics showing recession resistance and underlying business dynamics to back them up.
Is it a good time to scoop up last month's biggest losers? Check out October's largest price drops on the Nasdaq, and see whether any of them look like good buys today.